Oppenheimer Reiterates Outperform Rating on UroGen Pharma (URGN), 'reiterate URGN as a top pick'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: URGN) | Delayed: 32.72 -0.76 (2.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.48 | 52 Week High | $ | |||
| Open | $33.14 | 52 Week Low | $ | |||
| Day High | $33.65 | P/E | N/A | |||
| Day Low | $32.39 | EPS | $ | |||
| Volume | 1,167,550 | |||||
